TACE (CT) Blocking PeptideTACE (CT) Blocking Peptide
Move your mouse over image or click to enlarge

TACE (CT) Blocking Peptide

TACE (tumor necrosis factor-α-converting enzyme) is a pleiotropic metalloprotease also known as ADAM17 that is found to be constitutively expressed by intestinal epithelial cells.1 TACE is a major sheddase of TNF-α and its receptors, essential for the generation of soluble, mature molecules.2 TACE as a promising target of epidermal growth factor receptor (EGFR) axis inhibition in colorectal cancer (CRC)3 and a principal target for the treatment of TNF-dependent pathologies.4
Cat# Size Price Qty Buy
T204-50ug 50ug £103.13

Additional Information

Property Value or Rating
Manufacturer Cat# T204
Product Size 50ug
Concentration 0.2 mg/ml
Formulation This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Manufacturer Leinco Technologies Inc
Alternate Names Tumor Necrosis Factor-a a alpha Converting Enzyme Tumor Necrosis Factora a alpha Converting Enzyme Tumor Necrosis Factor a a alpha Converting Enzyme TACE CT Blocking Peptide TACE TACE CT Blocking Peptide ADAM17 CD156b MGC71942 cSVP TACE CT Blocking Peptide Blocking Peptide Tumor Necrosis Factor-a a alpha Converting Enzyme ADAM17 CD156b MGC71942 cSVP TACE Human TACE CT Blocking Peptide Blocking Peptide Tumor Necrosis Factora a alpha Converting Enzyme ADAM17 CD156b MGC71942 cSVP TACE Human TACE CT Blocking Peptide Blocking Peptide Tumor Necrosis Factor a a alpha Converting Enzyme ADAM17 CD156b MGC71942 cSVP TACE Human TACE CT Blocking Peptide TACE CT Blocking Peptide
Storage Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Protein Tumor Necrosis Factor-α Converting Enzyme

Related Documents